The risk of malignancy associated with psoriasis

Archives of Dermatology

Volumn 137, Issue 6, 2001, Pages 778-783

  Margolis, David ^a,b   Bilker, Warren ^a   Hennessy, Sean ^a   Vittorio, Carmela ^b   Santanna, Jill ^a   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETRETINATE; METHOTREXATE; METHOXSALEN; TACROLIMUS;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; ECZEMA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PSORIASIS;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MEDICAID; MEDICAL RECORDS; MID-ATLANTIC REGION; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS;

EID: 0034973031     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Psoriasis
2. Therapeutic strategies for psoriasis
3. Psoriasis: A review of present and future management
4. Psoriasis, PUVA, and skin cancer - Molecular epidemiology: The curious question of T→A transversions
5. Consensus workshop on the toxic effects of long-term PUVA therapy
6. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis: Do the known risks now outweigh the benefits?
7. Skin cancer in patients with psoriasis-many intertwined risk factors
8. Psoriasis, its treatment, and cancer in a cohort of Finnish patients
9. Treatment with UV-B for psoriasis and nonmelanoma skin cancer: A systematic review of the literature
10. Noncutaneous malignant tumors in the PUVA Follow-up Study: 1975-1996
11. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet-A radiation (PUVA): The PUVA follow-up study
12. Oral psoralen and ultraviolet A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA follow-up study
13. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA): A meta-analysis
14. Medicaid databases
15. Count outcomes: Regression models for counts
16. Malignant tumours and psoriasis: A follow-up study
17. Breast and lung cancers in two cyclosporin-A-treated psoriatic women
18. Cyclosporine-associated lymphoma
19. Risk of malignancy associated with cyclosporin use in psoriasis
20. Sequential therapy of psoriasis: Introducing a new therapeutic paradigm for better clinical results
21. An approach to identifying incident breast cancer cases using Medicare claims data
22. PUVA and cancer risk: The Swedish follow-up study
23. Should PUVA be abandoned?